Home › Funds › WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC › RGEN

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC position in RGEN

Repligen Corp · Health Care

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reported holding 1,243,415 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$239.0M, representing 0.78% of its reported portfolio and ranking #23 among its reported holdings. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed RGEN holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.24M sh
Reported value held$239.02M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's RGEN position evolved

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC first disclosed a stake in RGEN in Q3 2023 at 946,893 shares (US$150.6M). The position peaked in Q3 2026 at 1,243,415 shares, worth US$239.0M. Across 5 filings, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,243,415 shares valued at US$239.0M — an increase of 454,844 shares quarter over quarter.. Notable position changes include a 30% trim in Q1 2024 (shares fell 31% over the following quarter), a 58% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 946.89K $150.57M New
Q4 2023 905.76K $162.86M Reduce
Q1 2024 634.99K $116.79M Reduce
Q2 2026 788.57K $107.59M New
Q3 2026 1.24M $239.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC held RGEN?

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed RGEN holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

What is WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's current position in RGEN?

As of Q3 2026, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds 1.24M shares of RGEN (Repligen Corp), valued at $239.02M, representing 0.78% of its reported portfolio and ranking #23.

Has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased its position in RGEN. The position peaked in Q3 2026 at 1.24M shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.